Abeona Therapeutics
ABEO
ABEO
40 hedge funds and large institutions have $52.5M invested in Abeona Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
14
Reduced
5
Closed
6
Calls
$491K
Puts
–
Net Calls
+$491K
Net Calls Change
-$57K
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.27M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.77M |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.09M |
| 4 |
Millennium Management
New York
|
+$1.27M |
| 5 |
Citigroup
New York
|
+$1.05M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$3.5M |
| 2 |
Goldman Sachs
New York
|
-$860K |
| 3 |
VF
Virtu Financial
New York
|
-$130K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$64.6K |
| 5 |
JGC
J. Goldman & Co
New York
|
-$11.4K |
